Literature DB >> 15386475

Chromosome 2q terminal deletion: report of 6 new patients and review of phenotype-breakpoint correlations in 66 individuals.

Kari A Casas1, Tarja K Mononen, Claudia N Mikail, Susan J Hassed, Shibo Li, John J Mulvihill, Henry J Lin, Rena E Falk.   

Abstract

We report a new patient with terminal deletion of chromosome 2 with breakpoint at 2q36 and five additional new patients with 2q terminal deletion with breakpoint at 2q37. Hemidiaphragmatic hernia is a novel finding in one patient with a breakpoint at 2q37.1. In comparing these patients to 60 previously reported individuals with 2q terminal deletions, certain physical abnormalities are loosely associated with positions of breakpoint. For example, facial features (e.g., prominent forehead, depressed nasal bridge, and dysmorphic ears and nose), short stature, and short hands and feet were frequent in patients with breakpoints at or proximal to 2q37.3. Reports of horseshoe kidney and Wilms tumor were limited to patients with a breakpoint at 2q37.1, and structural brain anomalies and tracheal anomalies were reported only in patients with breakpoints at or proximal to 2q37.1. Cleft palate was reported only in patients with the most proximal breakpoints (2q36 or 2q35). Neurological effects including developmental delay, mental retardation, autistic-like behavior, and hypotonia were typical in this patient population but did not stratify in severity according to breakpoint. Terminal deletion of the long arm of chromosome 2 should be considered in the infant with marked hypotonia, poor feeding, gastroesophageal reflux, and growth delay, and the older child with developmental delay, autistic behavior, and the characteristic facial and integumentary features described herein. Assignment of clinical features to specific breakpoints and refinement of predictive value may be useful in counseling. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15386475     DOI: 10.1002/ajmg.a.30156

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  27 in total

1.  A genome-wide scan for genes involved in primary vesicoureteric reflux.

Authors:  H Kelly; C M Molony; J M Darlow; M E Pirker; A Yoneda; A J Green; P Puri; D E Barton
Journal:  J Med Genet       Date:  2007-07-27       Impact factor: 6.318

Review 2.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

Review 3.  Genetics of vesicoureteral reflux.

Authors:  Prem Puri; Jan-Hendrik Gosemann; John Darlow; David E Barton
Journal:  Nat Rev Urol       Date:  2011-08-23       Impact factor: 14.432

4.  Paracentric inversion of chromosome 2 associated with cryptic duplication of 2q14 and deletion of 2q37 in a patient with autism.

Authors:  Françoise Devillard; Vincent Guinchat; Daniel Moreno-De-Luca; Anne-Claude Tabet; Nicolas Gruchy; Pascale Guillem; Marie-Ange Nguyen Morel; Nathalie Leporrier; Marion Leboyer; Pierre-Simon Jouk; James Lespinasse; Catalina Betancur
Journal:  Am J Med Genet A       Date:  2010-09       Impact factor: 2.802

5.  Focal Xanthogranulomatous Pyelonephritis in Brachydactyly Mental Retardation Syndrome (2q37 Deletion Syndrome).

Authors:  Esra Nagehan Akyol Onder; Mine Ozkol; Nalan Nese; Can Taneli; Osman Orkun Cankorur; Ipek Ozunan
Journal:  J Pediatr Genet       Date:  2019-09-23

6.  Reorganization of inter-chromosomal interactions in the 2q37-deletion syndrome.

Authors:  Philipp G Maass; Anja Weise; Katharina Rittscher; Julia Lichtenwald; A Rasim Barutcu; Thomas Liehr; Atakan Aydin; Yvette Wefeld-Neuenfeld; Laura Pölsler; Sigrid Tinschert; John L Rinn; Friedrich C Luft; Sylvia Bähring
Journal:  EMBO J       Date:  2018-06-19       Impact factor: 11.598

7.  The 2q37-deletion syndrome: an update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients.

Authors:  Camille Leroy; Emilie Landais; Sylvain Briault; Albert David; Olivier Tassy; Nicolas Gruchy; Bruno Delobel; Marie-José Grégoire; Bruno Leheup; Laurence Taine; Didier Lacombe; Marie-Ange Delrue; Annick Toutain; Agathe Paubel; Francine Mugneret; Christel Thauvin-Robinet; Stéphanie Arpin; Cedric Le Caignec; Philippe Jonveaux; Mylène Beri; Nathalie Leporrier; Jacques Motte; Caroline Fiquet; Olivier Brichet; Monique Mozelle-Nivoix; Pascal Sabouraud; Nathalie Golovkine; Nathalie Bednarek; Dominique Gaillard; Martine Doco-Fenzy
Journal:  Eur J Hum Genet       Date:  2012-10-17       Impact factor: 4.246

Review 8.  Syndromic autism: causes and pathogenetic pathways.

Authors:  Arianna Benvenuto; Romina Moavero; Riccardo Alessandrelli; Barbara Manzi; Paolo Curatolo
Journal:  World J Pediatr       Date:  2009-08-20       Impact factor: 2.764

9.  Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE.

Authors:  Jill A Rosenfeld; Blake C Ballif; Donna M Martin; Arthur S Aylsworth; Bassem A Bejjani; Beth S Torchia; Lisa G Shaffer
Journal:  Hum Genet       Date:  2010-04       Impact factor: 4.132

10.  Recent advances in the pathogenesis of syndromic autisms.

Authors:  A Benvenuto; B Manzi; R Alessandrelli; C Galasso; P Curatolo
Journal:  Int J Pediatr       Date:  2009-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.